- Home
- IQV vs CUK Comparison
IQV vs CUK Comparison
Compare IQV & CUK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IQV | CUK |
|---|---|---|
| Founded | 1982 | 1972 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.4B | 34.2B |
| IPO Year | 2013 | 2000 |
Fundamental Metrics
Financial Performance| Metric | IQV | CUK |
|---|---|---|
| Price | $226.07 | $31.10 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 15 | 19 |
| Target Price | ★ $236.93 | $35.53 |
| AVG Volume (30 Days) | 1.4M | ★ 2.2M |
| Earning Date | 02-05-2026 | 12-19-2025 |
| Dividend Yield | N/A | ★ 0.48% |
| EPS Growth | N/A | ★ 40.51 |
| EPS | ★ 7.30 | 2.02 |
| Revenue | $15,904,000,000.00 | ★ $26,622,000,000.00 |
| Revenue This Year | $6.14 | $7.18 |
| Revenue Next Year | $5.35 | $3.87 |
| P/E Ratio | $30.95 | ★ $14.86 |
| Revenue Growth | 3.85 | ★ 6.40 |
| 52 Week Low | $134.65 | $13.65 |
| 52 Week High | $234.30 | $32.65 |
Technical Indicators
Market Signals| Indicator | IQV | CUK |
|---|---|---|
| Relative Strength Index (RSI) | 56.45 | 75.55 |
| Support Level | $219.91 | $25.97 |
| Resistance Level | $225.80 | $32.65 |
| Average True Range (ATR) | 4.24 | 1.01 |
| MACD | -0.32 | 0.81 |
| Stochastic Oscillator | 92.20 | 83.35 |
Price Performance
Historical ComparisonAbout IQV IQVIA Holdings Inc.
Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.
About CUK Carnival Plc ADS ADS
Carnival is the largest global cruise company, with more than 90 ships in service. Its portfolio of brands includes Carnival Cruise Lines, Holland America, Princess Cruises, and Seabourn in North America; P&O Cruises and Cunard Line in the United Kingdom; Aida in Germany; Costa Cruises in Southern Europe. It recently folded its P&O Australia brand into Carnival. The firm also owns Holland America Princess Alaska Tours in Alaska and the Canadian Yukon. Carnival's brands attracted 14 million guests in 2024.